3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Multiple Myeloma
90
Neoplasms, Plasma Cell
28
Central Nervous System Neoplasms
11
Recurrence
10
Glioblastoma
10
Neoplasms
9
Carcinoma, Hepatocellular
9
Brain Neoplasms
9
Gliosarcoma
8
Melanoma
6
Lung Neoplasms
6
Leukemia
6
Glioma
6
Carcinoma, Non-Small-Cell Lung
6
Waldenstrom Macroglobulinemia
5
Prostatic Neoplasms
5
Lymphoma, Mantle-Cell
5
Myeloproliferative Disorders
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Immunoglobulin Light-chain Amyloidosis
4
Colorectal Neoplasms
4
Carcinoma, Renal Cell
4
Astrocytoma
4
Uveal Melanoma
3
Oligodendroglioma
3
Neuroblastoma
3
Myelodysplastic-Myeloproliferative Diseases
3
Myelodysplastic Syndromes
3
Medulloblastoma
3
Interventions
Dexamethasone
29
Aprepitant
24
Palonosetron
20
Ondansetron
20
Calcium Dobesilate
13
Olanzapine
12
Granisetron
11
Therapeutics
7
fosaprepitant
6
Doxorubicin
6
Cyclophosphamide
6
dexamethasone acetate
5
netupitant
4
Vincristine
4
dolasetron
3
Yoga
3
Tropisetron
3
Surveys and Questionnaires
3
Psychiatric Rehabilitation
3
Prochlorperazine
3
Metoclopramide
3
Lorazepam
3
Dronabinol
3
Acupressure
3
peppermint oil
2
netupitant, palosentron drug combination
2
ginger extract
2
dexamethasone 21-phosphate
2
Sugars
2
Rituximab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Nausea
×
Thalidomide
×
Clear all
NCT06017284
2023-11-24
PTCA199-5
Fudan University
Phase 3
Recruiting
100 enrolled